Characterization of circulating HIV type 1 env genes in plasma of two antiretroviral-naive slow progressing patients with broad neutralizing antibody response with evidence of recombination

AIDS Research and Human Retroviruses

Volumn 28, Issue 7, 2012, Pages 739-745

  Mukhopadhyay, Sampurna ^a   Ringe, Rajesh ^a   Patil, Ajit ^a   Paranjape, Ramesh ^a   Bhattacharya, Jayanta ^a  

^a Maharashtra Industrial Development Corporation India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GLYCOPROTEIN GP 160; NEUTRALIZING ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY RESPONSE; CASE REPORT; CLADISTICS; CLONE; CONTROLLED STUDY; ENVELOPE GENE; GENE AMPLIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMORAL IMMUNITY; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SPECIES; VIRUS RECOMBINATION; VIRUS STRAIN;

ADULT; ANTIBODIES, NEUTRALIZING; BASE SEQUENCE; GENETIC HETEROGENEITY; HIV ENVELOPE PROTEIN GP120; HIV SEROPOSITIVITY; HIV-1; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; PHYLOGENY;

EID: 84857790675     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0238     Document Type: Review

References (33)

1. Goodenow M, Huet T, Saurin W, et al.: HIV-1 isolates are rapidly evolving quasispecies: Evidence for viral mixtures and preferred nucleotide substitutions. J Acquir Immune Defic Syndr 1989;2:344-352. (Pubitemid 19200207)
2. Malim MH and Emerman M: HIV-1 sequence variation: Drift, shift, and attenuation. Cell 2001;104:469-472. (Pubitemid 32201943)
3. Asjo B, Morfeldt-Manson L, Albert J, et al.: Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet 1986;2:660-662. (Pubitemid 16029378)
4. Cheng-Mayer C, Seto D, Tateno M, et al.: Biologic features of HIV-1 that correlate with virulence in the host. Science 1988;240:80-82.
5. Tersmette M, Gruters RA, de Wolf F, et al.: Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: Studies on sequential HIV isolates. J Virol 1989; 63:2118-2125. (Pubitemid 19107808)
6. Anzala OA, Nagelkerke NJ, Bwayo JJ, et al.: Rapid progression to disease in African sex workers with human immunodeficiency virus type 1 infection. J Infect Dis 1995;171: 686-689.
7. Albert J, Abrahamsson B, Nagy K, Aurelius E, et al.: Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. AIDS 1990;4:107-112. (Pubitemid 20108767)
8. Arendrup M, Sonnerborg A, Svennerholm B, et al.: Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape. J Gen Virol 1993;74(Pt 5):855-863. (Pubitemid 23154286)
9. Nowak MA, Anderson RM, McLean AR, et al.: Antigenic diversity thresholds and the development of AIDS. Science 1991;254:963-969. (Pubitemid 21917418)
10. Wolfs TF, Zwart G, Bakker M, et al.: Naturally occurring mutations within HIV-1 V3 genomic RNA lead to antigenic variation dependent on a single amino acid substitution. Virology 1991;185:195-205.
11. Diaz RS, Sabino EC, Mayer A, et al.: Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient. The Transfusion Safety Study Group. J Virol 1995;69:3273-3281.
12. Brander C, Frahm N, and Walker BD: The challenges of host and viral diversity in HIV vaccine design. Curr Opin Immunol 2006;18:430-437. (Pubitemid 43947582)
13. Walker BD and Burton DR: Toward an AIDS vaccine. Science 2008,320:760-764. (Pubitemid 351929619)
14. Thomson MM, Perez-Alvarez L, and Najera R: Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Lancet Infect Dis 2002; 2:461-471. (Pubitemid 34826851)
15. Gao F, Robertson DL, Carruthers CD, et al.: A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol 1998;72:5680-5698. (Pubitemid 28283353)
16. Sabino EC, Shpaer EG, Morgado MG, et al.: Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol 1994;68: 6340-6346. (Pubitemid 24294885)
17. Robertson DL, Sharp PM, McCutchan FE, et al.: Recombination in HIV-1. Nature 1995;374:124-126.
18. Kampinga GA, Simonon A, Van de Perre P, et al.: Primary infections with HIV-1 of women and their offspring in Rwanda: Findings of heterogeneity at seroconversion, coinfection, and recombinants of HIV-1 subtypes A and C. Virology 1997;227:63-76. (Pubitemid 27241055)
19. Fang G, Weiser B, Kuiken C, et al.: Recombination following superinfection by HIV-1. AIDS 2004;18:153-159. (Pubitemid 38253436)
20. Ringe R, Thakar M, and Bhattacharya J: Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naive Indian patients with recent infection. Retrovirology 2010;7:76.
21. Li M, Gao F, Mascola JR, et al.: Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccineelicited neutralizing antibodies. J Virol 2005;79:10108-10125. (Pubitemid 41098552)
22. Lakhashe S, Tripathy S, Paranjape R, et al.: Characterization of B/C recombinants of near full-length HIV type 1 from northeastern India with mosaics identical to ARE195FL but with a different ancestral origin. AIDS Res Hum Retroviruses 2008;24:92-99.
23. Lole KS, Bollinger RC, Paranjape RS, et al.: Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73:152-160. (Pubitemid 28565356)
24. Kijak GH, Tovanabutra S, Sanders-Buell E, et al.: Distinguishing molecular forms of HIV-1 in Asia with a highthroughput, fluorescent genotyping assay, MHAbce v.2. Virology 2007;358:178-191. (Pubitemid 46061427)
25. Gottlieb GS, Nickle DC, Jensen MA, et al.: Dual HIV-1 infection associated with rapid disease progression. Lancet 2004;363:619-622. (Pubitemid 38264182)
26. Chohan B, Lavreys L, Rainwater SM, et al.: Evidence for frequent reinfection with human immunodeficiency virus type 1 of a different subtype. J Virol 2005;79:10701-10708. (Pubitemid 41098609)
27. Piantadosi A, Chohan B, Chohan V, et al.: Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog 2007;3:e177.
28. Piantadosi A, Humes D, Chohan B, et al.: Analysis of the percentage of human immunodeficiency virus type 1 sequences that are hypermutated and markers of disease progression in a longitudinal cohort, including one individual with a partially defective Vif. J Virol 2009;83:7805-7814.
29. Templeton AR, Kramer MG, Jarvis J, et al.: Multiple-infection and recombination in HIV-1 within a longitudinal cohort of women. Retrovirology 2009;6:54.
30. McCutchan FE, Hoelscher M, Tovanabutra S, et al.: In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: Evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection. J Virol 2005;79:11693-11704. (Pubitemid 41279288)
31. Braibant M, Agut H, Rouzioux C, et al.: Characteristics of the env genes of HIV type 1 quasispecies in long-term nonprogressors with broadly neutralizing antibodies. J Acquir Immune Defic Syndr 2008;47:274-284. (Pubitemid 351619411)
32. Wang B, Dyer WB, Zaunders JJ, et al.: Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection. Virology 2002;304:246-264. (Pubitemid 36069167)
33. Wang B, Mikhail M, Dyer WB, et al.: First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection. Virology 2003;312: 135-150. (Pubitemid 36918466)